Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors
Randomized Phase III Trial of Haploidentical HCT with or without an Add back Strategy of HSV-Tk Donor Lymphocytes in Patients with High Risk Acute Leukemia
Randomized study of autologous stem cell transplantation with high-dose melphalan versus high-dose melphalan and bortezomib in patients with MM 60 years or older
A Pilot Study of Telmisartan (Micardis) for the Prevention of Acute Graft Versus Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation
A Phase III study of Fludarabine and Busulfan versus Fludarabine, Busulfan and low dose total body irradiation in patients receiving an allogeneic hematopoietic stem cell transplant
Tandem Autologoous Hematopoietic stem cell transplantation with melphalan folowed by melphalan and bortezomib in patients with multiple myeloma
Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients Who Have Enrolled on BMT CTN 0702 BMT CTN 0702 Long-Term Follow-Up Version 1.0 dated September 30, 2014
A Phase II Randomized Study of Adjuvant vs. Neoadjuvant MK-3475 (Pembrolizumab) for Clinically Detectable Stage III-IV High Risk Melanoma.